Approach to the management of diabetic patients with heart failure: Role of thiazolidinediones
- 1 October 2004
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 148 (4) , 551-558
- https://doi.org/10.1016/j.ahj.2004.04.033
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Trends in Management of Type 2 DiabetesThe Endocrinologist, 2003
- Glitazones and Heart FailureCirculation, 2003
- Metabolic and Additional Vascular Effects of ThiazolidinedionesDrugs, 2002
- Safety and tolerability of pioglitazoneExperimental and Clinical Endocrinology & Diabetes, 2000
- Pulmonary Edema Associated With Troglitazone TherapyArchives of internal medicine (1960), 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registryThe American Journal of Cardiology, 1996
- The epidemiology of heart failure: The Framingham StudyJournal of the American College of Cardiology, 1993
- RELATION BETWEEN PLASMA FREE FATTY ACIDS AND ARRHYTHMIAS WITHIN THE FIRST TWELVE HOURS OF ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1983
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974